Tenet Healthcare (NYSE: THC) reported Q2 EPS of $1.50, $0.87 better than the analyst estimate of $0.63. Revenue for the quarter came in at $4.64 billion versus the consensus estimate of $4.83 billion.

GUIDANCE:

Tenet Healthcare sees Q3 2022 revenue of $4.7-4.9 billion, versus the consensus of $4.92 billion.

Tenet Healthcare sees FY2022 revenue of $19-19.4 billion, versus the consensus of $19.74 billion. Reaffirms adjusted EBITDA outlook.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.